Saturday, June 27, 2026

🦈 Why Nuclear? Why Now? The AI Energy Math

 By Sharkwater Trading Analysis Team  |  June 27, 2026

Welcome to the shark tank, energy bulls. The feeding frenzy is on — and this time, the current is nuclear.

For decades, nuclear power sat in the penalty box. Aging plants. Regulatory nightmares. Three Mile Island. Chernobyl. Fukushima. Wall Street wanted nothing to do with it. But in 2024, something changed. Then in 2025 it changed more. And right now in 2026, we are living through what may be the most significant energy investment supercycle of the next twenty years — and the trigger is artificial intelligence.

AI data centers are voracious. The International Energy Agency now projects that global data center electricity consumption will triple by 2030. Goldman Sachs puts the number at a 165% surge in power demand from AI alone. The U.S. alone will need an estimated 50 gigawatts of new capacity by 2028 just to keep pace. Wind and solar can't deliver always-on baseload power. Natural gas is politically complicated. But nuclear? Nuclear runs 24 hours a day, 365 days a year, regardless of cloud cover or wind speed — and it produces zero carbon emissions.

Microsoft, Amazon, Google, and Meta didn't miss this memo. They've been quietly signing some of the most consequential energy deals in corporate history — and nearly all of them point to one source: nuclear power.

Today, Sharkwater is mapping every corner of this trade for you. Pure-play SMR developers. Uranium suppliers. Nuclear fleet operators. Grid infrastructure. The whole food chain. Let's hunt.


🦈 Why Nuclear? Why Now? The AI Energy Math

Let's get the macro straight before we start picking stocks, because the macro is what makes this trade work at every level of the food chain.

U.S. data center electricity demand is expected to explode from 176 TWh in 2023 to as much as 580 TWh by 2028 — that's according to Lawrence Berkeley National Lab. To put that in perspective, 580 TWh is roughly what the entire country of France consumes in a year. We need to build that much new power generation capacity in under five years.

The hyperscalers figured this out before almost anyone else. Look at what they've committed to since 2024:

CompanyNuclear DealCapacityDetails
MicrosoftThree Mile Island restart (Crane Clean Energy Center)835 MW20-year PPA with Constellation; entire plant output; targeting 2027 restart
AmazonX-energy Xe-100 SMR fleet320–960 MW$700M investment; 4 units (Phase 1), scalable to 12
GoogleKairos Power SMR fleet500 MWFirst-ever U.S. corporate SMR fleet deal; delivery 2030+
GoogleNextEra Energy (Iowa)600 MWReactivating Iowa's nuclear plant from 2029
MetaVistra Corp — 3 nuclear PPAs2,609 MWLargest nuclear uprates ever by a corporate customer; starts late 2026
MetaOklo — Aurora reactors~1,000 MWLong-term deal; part of Meta's 6.6 GW total nuclear commitment by 2035
WalmartConstellation (Dresden plant)176 MWDual 15-year contracts beginning 2029–2030

Over 13 nuclear deals totaling more than 9.7 gigawatts of committed capacity — and that number is still growing. This isn't a trend. This is a structural shift. And the Trump administration is pouring rocket fuel on it.

The Policy Tailwind: On May 23, 2025, President Trump signed four executive orders aimed directly at nuclear energy — reforming the NRC to mandate 18-month decision timelines on new reactor licenses, directing the DOE to rebuild the domestic nuclear supply chain, and setting a national goal of 400 gigawatts of nuclear capacity by 2050. That's four times what the U.S. operates today. The DOE has already awarded up to $800 million in federal cost-share to early SMR deployment projects. The wind is at nuclear's back like never before in a generation.

Now let's talk about who gets paid.


🦈 TIER 1: THE NUCLEAR FLEET OPERATORS — Current Power, Current Cash Flow

These are the sharks already in the water — companies operating real, producing nuclear plants today and signing billion-dollar PPAs with the biggest corporations in the world.


CEG — Constellation Energy | ~$263–$277 | Analyst Target: $360

If you want to own the nuclear renaissance without the pre-revenue risk of pure-play SMR developers, Constellation Energy is the anchor position. It operates the largest nuclear fleet in America — approximately 22 gigawatts across 21 reactors — and it's the company that is literally restarting Three Mile Island for Microsoft.

The Crane Clean Energy Center (the rebranded TMI Unit 1) is on track for a second-half 2027 restart, running ahead of schedule. The NRC cleared a major environmental hurdle in June 2026, and FERC approved the transfer of 760 MW of capacity interconnection rights just weeks ago. The entire 835 MW output is sold to Microsoft under a 20-year power purchase agreement. Walmart signed dual 15-year contracts for 176 MW at its Dresden plant beginning 2029. This company is not hunting for customers — the customers are hunting for it.

Analyst consensus sits at $360 average price target (range: $296–$441) against a current price of ~$265. That's 35%+ implied upside from a company with the most enviable nuclear asset base in the country and locked-in long-term cash flows from investment-grade counterparties like Microsoft and Walmart. CEG is the blue-chip entry point into this theme.

The Trade: Core long position. Buy on any sector-wide pullbacks. The 20-year PPA structure means near-guaranteed revenue regardless of spot electricity price volatility. This is the kind of stock you build around.


VST — Vistra Corp | ~$165 | Analyst Target: $225 (Strong Buy)

Vistra doesn't get enough credit. It's often lumped in with traditional utilities — but after its acquisition of Energy Harbor, Vistra now operates one of the largest competitive nuclear fleets in the U.S., including Comanche Peak (TX), Beaver Valley (PA), Perry (OH), and the Illinois plants at Braidwood, Byron, and Dresden.

On January 9, 2026, Vistra dropped a bombshell announcement: three 20-year PPAs with Meta covering 2,609 megawatts of nuclear power — the single largest nuclear uprate deal ever supported by a corporate buyer in American history. Deliveries begin in late 2026 with the full contract ramping to 2,609 MW by 2034. Goldman Sachs and Jefferies upgraded the stock immediately after the announcement.

19 analysts cover VST. The consensus is Strong Buy with an average target of $225. The stock is currently at $165 — a 36% discount to that average. With Meta locking in two-decades of cash flows and the broader nuclear renaissance lifting all boats, Vistra looks like a coiled spring.

The Trade: Strong Buy for total return. The Meta deal de-risks a massive chunk of Vistra's nuclear output for 20 years. Watch for additional corporate PPA announcements — each one is a potential catalyst. Position sizing note: Vistra carries meaningful debt from the Energy Harbor acquisition, so size accordingly.


🦈 TIER 2: THE SMR PURE-PLAYS — Tomorrow's Power, Today's Opportunity

This is where it gets exciting — and where the risk profile changes significantly. Small Modular Reactors are the future of nuclear. Smaller footprint, faster to build, factory-manufactured, and designed specifically for the kind of modular, on-site power that data centers need. None of these companies have commercial revenue yet at scale. But the pipelines, partnerships, and regulatory milestones are starting to stack up fast.


XE — X-energy | ~$28.67 | Analyst Target: $39.86 | Amazon-Backed

Let's clear something up first: when you see "XE" in nuclear discussions, this is X-energy, Inc. — not Constellation Energy (that's CEG). X-energy completed its IPO on April 24, 2026, raising approximately $1.1 billion on the Nasdaq. Fresh money, fresh ticker, and one of the most credible backers in the business: Amazon invested $700 million into X-energy and is a committed customer for up to 12 of its Xe-100 reactor units.

The Xe-100 is a high-temperature gas-cooled reactor (HTGR) producing 80 megawatts of electricity per unit. Stack four of them together and you have a 320 MW power plant that can power roughly 240,000 homes — or a very large data center campus. X-energy is also part of the DOE's Reactor Pilot Program, giving it federal support alongside commercial backing.

Eight analysts cover XE with an average 12-month price target of $39.86 against a current price near $28.67 — roughly 39% implied upside. As a recent IPO, price discovery is still happening, and early-stage volatility should be expected. But the Amazon anchor and the $1.1B in fresh capital give X-energy a serious runway to reach first commercial deployment.

The Trade: Speculative long — best for traders comfortable with pre-revenue, pre-deployment risk. The Amazon relationship is the moat. Watch for NRC pre-application activities and DOE Pilot Program milestones as near-term catalysts. Consider scaling in rather than a single entry given IPO volatility.


OKLO — Oklo Inc. | ~$61 | Analyst Target: $90.41 | Sam Altman's Nuclear Bet

If OKLO had a mascot it would be a Great White in a three-piece suit. Backed by OpenAI's Sam Altman (who serves as Chairman), Oklo is developing the Aurora fast fission reactor — starting at 1.5 MWe and scaling toward 50 MWe per unit. It currently boasts a staggering 14 gigawatt customer pipeline, anchored by Switch's 12 GW data center power agreement.

June 2026 was a landmark month for Oklo. The Department of Energy issued preliminary safety approval for Oklo's first Aurora Powerhouse at Idaho National Laboratory — the first time the DOE has granted this level of regulatory clearance to an advanced fission company. That same week, Oklo signed a Letter of Intent with Centrus Energy for HALEU fuel supply — enough enriched uranium for up to five Aurora reactors, with delivery beginning 2029. Meta's nuclear commitment also includes an Oklo component as part of its 6.6 GW total pledge.

Oklo sits on $2.5 billion in cash and marketable securities — an enviable war chest for a pre-revenue company. First Aurora deployment is targeted for late 2027. The stock is down 21% YTD from its highs but still carries a market cap of $9.4 billion, reflecting the market's confidence in the pipeline and the Altman halo.

The Trade: High-conviction speculative long. The DOE safety approval in June 2026 is a genuine de-risking event — not just an MOU or a handshake. The Centrus fuel deal anchors the supply chain. Watch the INL deployment timeline closely; first criticality at Idaho National Lab is the next major catalyst. The 21% YTD pullback may offer a reasonable entry versus the $90 analyst target.


SMR — NuScale Power | ~$12–$13 | Analyst Target: $15.36

NuScale holds a unique position in the SMR landscape: it's the only company with an NRC-certified SMR design. The NuScale Power Module (77 MWe) received NRC design certification in 2022 — a regulatory milestone no other advanced reactor developer has achieved. In a world where NRC approval timelines have historically stretched for years, NuScale's certified design is a genuine competitive moat.

That said, Sharks need to know the full story. NuScale's cancellation of its UAMPS Carbon Free Power Project in 2023 — a high-profile first commercial deployment — shook investor confidence and the stock has never fully recovered. Revenue remains primarily development-stage and government-contract based. The path from "NRC-certified design" to "operating plant" still requires a customer willing to commit to a first-of-a-kind deployment.

Recent positive signals: NuScale opened a new Houston Operations Center (April 2026) to be closer to petrochemical and data center customers in Texas, secured a safety milestone on its Highly Integrated Protection System, and formed a Framatome partnership for European fuel fabrication. The company holds approximately $1 billion in liquidity, providing runway.

17 analysts cover NuScale with an average target of $15.36 and a Hold consensus — more cautious than the other SMR names. The upside from $12–$13 to $15 is real but modest. NuScale is a "show me" story: the catalyst you need is a definitive, signed commercial customer contract for a U.S. deployment.

The Trade: Speculative — lower conviction than OKLO or XE. Hold the NRC-certified design as a trump card. Consider a smaller position and watch for a commercial contract announcement as the trigger to add size. This one needs patience.


NNE — Nano Nuclear Energy | ~$21.33 | Analyst Target: $45 | Roth Capital Buy

Nano Nuclear is the most speculative name in this group — and also potentially the most interesting for traders who like to get in early on emerging themes. NNE is developing microreactors — the "ZEUS" and "ODIN" designs that are portable, deployable units aimed at remote sites, military applications, and eventually AI data centers.

The company has been making real moves behind the speculative buzz. It filed a Construction Permit Application with the NRC for its Kronos Microreactor Manufacturing and Research Reactor (MMR). It acquired Specialized Transportation Services — a nuclear logistics and transport company — giving it a full-stack capability from manufacture to fuel delivery to deployment. And it signed a significant MOU with Supermicro (SMCI) to explore powering AI data centers directly with microreactor technology.

NNE sits on $569 million in cash with a $400 million ATM facility untapped — plenty of fuel in the tank. Roth Capital is the most vocal institutional voice, initiating with a Buy and a $45 target against the current $21 price — more than 100% implied upside. The 52-week range of $18.93 to $60.87 tells you exactly what kind of volatility ride this is.

The Trade: Small, speculative position for aggressive traders. The microreactor thesis is real — military and remote site applications are genuine near-term markets. The Supermicro MOU plants a flag for the data center use case. But this is the furthest from revenue of any name on this list. Treat it like a venture bet, not a value play. Size accordingly.


🦈 TIER 3: THE NUCLEAR PICKS AND SHOVELS — Less Glamour, More Certainty

Every gold rush makes millionaires out of the people selling the picks and shovels. The nuclear renaissance is no different. These companies don't need to build a single new reactor to win — they supply the fuel, the components, and the grid infrastructure that make all of this work.


BWXT — BWX Technologies | ~$198 | Analyst Target: $238 | Buy

BWX Technologies is the nuclear supply chain in a single stock. BWXT manufactures fuel and reactor components for the entire U.S. Naval Nuclear Propulsion Program — every nuclear-powered submarine and aircraft carrier in the U.S. Navy runs on BWXT fuel and components. That alone gives it a government-backed revenue base that will grow as the Navy expands its fleet.

But BWXT is also positioned for the commercial nuclear renaissance. It manufactures reactor components for existing commercial plants, produces medical radioisotopes (a fast-growing business independent of power markets), and licensed its mPower SMR technology to Applied Atomics for next-generation deployment.

The Q1 2026 numbers were exceptional: 26% revenue growth, 22% EPS growth, and order backlog up 77% year-over-year. The $200M PCG acquisition expanded its manufacturing capability, and a new U.S. facility is in planning. 15 analysts cover BWXT with 8 Buy ratings and an average target of $238 — about 20% above the current price of $198.

The Trade: Core long position. BWXT is the lowest-risk way to play the nuclear buildout — government contracts provide floor, commercial upside provides ceiling. The 77% backlog growth in one quarter tells you everything about where orders are headed. Sleep well at night holding this one.


LEU — Centrus Energy | ~$166–$172 | Analyst Target: $274 | Buy

Centrus Energy is the only U.S. company authorized by the NRC to produce HALEU — High-Assay Low-Enriched Uranium, the fuel that most advanced SMRs require. You can build the most sophisticated reactor in the world, but without HALEU, it's a very expensive paperweight. Centrus is the chokepoint in the entire SMR supply chain.

The business has been firing on all cylinders in 2026. The DOE awarded Centrus a $900 million HALEU production contract in Q1 2026, and the company raised its full-year 2026 revenue guidance to $450–500 million as a result. Its order backlog now stretches to $3.9 billion through 2040 — extraordinary long-term visibility for a company with a market cap in the $2–3 billion range.

The June 18, 2026 announcement that Centrus signed an LOI with Oklo to supply HALEU for up to five Aurora reactors beginning in 2029 is a perfect encapsulation of the leverage here: as each SMR developer reaches deployment, they all have to come to Centrus. There is no domestic alternative for HALEU at commercial scale.

One caveat Sharks need to respect: the 52-week range of $144.65 to $464.25 is not a typo. Centrus has been brutally volatile — trading near $464 at its highs and now sitting around $170. The 11-analyst average price target of $274 represents 60%+ upside from current levels, but you need to be mentally prepared for significant price swings.

The Trade: High-conviction long for patient traders. The fundamental moat (sole domestic HALEU supplier) gets more valuable as each SMR project matures. The $900M DOE contract and $3.9B backlog provide a floor. The volatility is real — consider a staged entry over several weeks rather than a single print.


GEV — GE Vernova | ~$1,057 | Analyst Target: $1,212 | Buy (30 analysts, 0 sells)

GE Vernova is the ultimate picks-and-shovels play for the entire energy transition — not just nuclear. Spun out of General Electric in April 2024, GEV manufactures the gas turbines, grid solutions, electrification equipment, and nuclear steam components that power both the existing grid and the nuclear buildout simultaneously.

The Q1 2026 results were staggering: orders up 71% year-over-year, revenue growing at a rapid clip, and total backlog expanded by $13 billion to reach $163 billion. The company raised its 2026 revenue guidance to $44.5–$45.5 billion. GEV has near-monopoly positioning on large gas turbines — the backup generation that data centers absolutely require — and it services nuclear plants globally, including new builds like Hinkley Point in the UK.

30 analysts cover GEV. Zero have sell ratings. The average price target is $1,212 against a current price of ~$1,057 — about 15% upside. It's not the highest-return opportunity on this list, but it might be the highest-quality one. This is a Berkshire-level business hidden inside an energy-transition story.

The Trade: Long-term core position. Own GEV for the multi-year energy infrastructure supercycle — data centers need more gas backup, the nuclear fleet needs servicing, and the grid needs upgrades. The 30-0 analyst consensus says it all. If you want one stock to own for the next decade of the energy transition, GEV is in the conversation.


🦈 TIER 4: THE URANIUM FOOD CHAIN — Fuel for the Renaissance

No uranium, no nuclear renaissance. As the world commits to building hundreds of new reactors over the next two decades, the demand for uranium — both conventional enriched uranium and advanced HALEU — is going to ratchet up dramatically. The spot price is cyclical, but the long-term contract market is what matters here, and utilities are locking in supply now at higher prices than they've agreed to in years.


CCJ — Cameco | ~$109 | Analyst Target: $140–$175 | Buy

Cameco is the world's largest publicly traded uranium company, operating the Cigar Lake and McArthur River mines in Saskatchewan — two of the highest-grade uranium deposits on the planet. If the nuclear renaissance is real, Cameco prints money. It's that simple.

What makes Cameco even more interesting is its 49% stake in Westinghouse Electric — the global leader in nuclear reactor design, engineering, and services, shared with Brookfield. Westinghouse has its fingers in virtually every new reactor build globally, from the AP1000 fleet in the U.S. to international projects across Europe and Asia. Owning Cameco is owning the uranium mine and a piece of the world's dominant nuclear services firm.

Scotiabank recently raised its price target on CCJ to $175 from $150 — a vote of confidence in the long-term uranium demand thesis. Current price near $109. Strong Buy consensus from the analyst community.

The Trade: Long-term core uranium position. Buy Cameco when uranium spot prices pull back — the long-term contract repricing cycle has years to run. The Westinghouse stake gives you leverage to the global reactor buildout that doesn't depend on uranium pricing at all.


UEC — Uranium Energy Corp | ~$10.66 | Analyst Target: $18 | Strong Buy

UEC is the scrappier, higher-beta uranium play for traders who want more torque. Uranium Energy focuses on in-situ recovery (ISR) uranium mining in Texas and Wyoming — a lower-cost, lower-environmental-impact extraction method that works well in the U.S. regulatory environment. ISR doesn't require open-pit mines or underground operations; uranium is dissolved from the ore in place and pumped to the surface.

The Trump administration's "energy dominance" push specifically favors domestic uranium sourcing, and UEC is one of the few pure-play domestic producers capable of scaling production quickly. The company also holds a physical uranium inventory that provides NAV support independent of production timing.

The numbers tell a compelling story: 9 analysts covering with a Strong Buy consensus, a median price target of $18 against a current price of $10.66 — nearly 70% implied upside. The 52-week range of $5.90 to $20.34 reflects the cyclical volatility of uranium stocks, but the direction of the long-term trend is clear.

The Trade: Speculative long with strong fundamental support. Size it for the volatility — this is not a $5.90 stock you buy all at once at $10. Accumulate on weakness and hold for the domestic uranium demand cycle. The 70% implied upside to analyst targets is hard to ignore at current levels.


🦈 The Full Scorecard: Every Name, Ranked by Conviction

TierTickerCompanyPriceAnalyst TargetImplied UpsideRisk LevelSharkwater Conviction
Fleet OperatorCEGConstellation Energy~$265$360+36%Low-Medium⭐⭐⭐⭐⭐
Fleet OperatorVSTVistra Corp~$165$225+36%Medium⭐⭐⭐⭐⭐
Picks & ShovelsBWXTBWX Technologies~$198$238+20%Low⭐⭐⭐⭐⭐
Picks & ShovelsGEVGE Vernova~$1,057$1,212+15%Low-Medium⭐⭐⭐⭐⭐
UraniumCCJCameco~$109$140–$175+28–60%Medium⭐⭐⭐⭐⭐
Fuel SupplyLEUCentrus Energy~$170$274+61%Medium-High⭐⭐⭐⭐☆
SMR DeveloperOKLOOklo Inc.~$61$90+48%High⭐⭐⭐⭐☆
SMR DeveloperXEX-energy~$29$40+39%High⭐⭐⭐⭐☆
UraniumUECUranium Energy Corp~$10.66$18+69%High⭐⭐⭐☆☆
SMR DeveloperSMRNuScale Power~$12–$13$15.36+20%High⭐⭐⭐☆☆
MicroreactorNNENano Nuclear Energy~$21$45+100%+Very High⭐⭐☆☆☆

🦈 The Key Milestones to Watch — Your Trading Calendar

In a theme this multi-year, milestones are your catalysts. Every NRC approval, every signed PPA, every DOE award is a potential price mover. Here's the calendar that matters:

  • July 8, 2026: NRC public comment deadline for Crane Clean Energy Center (TMI) Environmental Assessment — clearance here keeps the 2027 restart on track for CEG
  • Late 2026: Vistra begins delivering first nuclear power to Meta under its 2,609 MW agreement — first real cash flow from the landmark deal; VST catalyst
  • Late 2027: Crane Clean Energy Center (TMI) targeted restart — biggest single nuclear power event in the U.S. in decades; CEG and the entire sector likely re-rates
  • Late 2027: Oklo's first Aurora reactor at Idaho National Laboratory — if achieved, transforms Oklo from pre-revenue story to operational company; massive OKLO catalyst
  • 2029: Centrus begins HALEU deliveries to Oklo; Google/NextEra Iowa nuclear plant reactivation; Walmart/CEG Dresden contracts begin — multiple LEU and CEG catalysts
  • 2030+: Google/Kairos Power SMR fleet first power; NuScale first U.S. commercial modules — sector validation events that lift all SMR names
  • 2035: Meta's total 6.6 GW nuclear commitment fully online — the largest single corporate nuclear portfolio in history
  • 2050: U.S. target of 400 GW nuclear (vs. ~100 GW today) — the generational backdrop against which every trade on this list takes place

🦈 How to Build the Nuclear Portfolio: The Sharkwater Framework

Not every investor has the same risk appetite, and the nuclear trade is not one-size-fits-all. Here's how we think about constructing exposure across the food chain:

Conservative Sharks — You want the nuclear theme with minimal binary risk. Focus on CEG, VST, BWXT, and GEV. These companies have real revenue, real cash flows, and real assets. The nuclear renaissance makes them grow faster, but the floor doesn't disappear if one SMR project slips a year.

Balanced Sharks — Add CCJ and LEU to the core positions above. Cameco gives you the uranium commodity play with Westinghouse optionality. Centrus gives you the HALEU chokepoint — the one supply that every advanced SMR must eventually buy. Combined with the operators, this builds a full food-chain position.

Aggressive Sharks — Layer in OKLO and XE as your high-beta, pre-revenue exposure. These are the names that double or triple if the deployment milestones hit — but they're also the ones that get cut in half on a regulatory delay or a broader risk-off tape. Keep position sizes disciplined; don't let speculation become your largest holding.

Apex Sharks OnlyNNE and UEC are for traders who understand they're making venture-style bets in public markets. The upside is real. So is the volatility. Size these at 1–3% of portfolio maximum and let the thesis develop over 18–24 months.


🦈 Risks Every Nuclear Shark Must Respect

We wouldn't be doing our job if we didn't call out the currents that could pull this trade underwater.

  • Regulatory timeline slippage: The Trump executive orders are meant to speed NRC approvals to 18 months. The NRC has a long history of exceeding timelines. Any slippage pushes deployment dates right and defers revenue for the pre-revenue names.
  • Construction cost overruns: Nuclear has a storied history of going massively over budget. First-of-a-kind SMR deployments carry higher construction risk than nth-of-a-kind plants. Watch for cost disclosures carefully.
  • Technology risk in advanced designs: Fast fission (Oklo), high-temperature gas-cooled (X-energy), and microreactor designs have never operated at commercial scale. Technical hurdles could delay deployment.
  • Uranium price volatility: CCJ and UEC are commodity businesses. Uranium spot prices can drop sharply on market dislocations, oversupply rumors, or reduced reactor commitments globally.
  • Policy reversal: This administration is strongly pro-nuclear. A future administration could change priorities, slow federal support, or delay DOE cost-share programs.
  • Big Tech capex pullback: If AI spending growth slows materially, hyperscaler demand for new power capacity could ease, reducing the urgency behind nuclear PPA signing.

🦈 Final Word: The Biggest Energy Trade of Our Generation

Sharks, we've been around long enough to recognize when a structural shift is happening in real time — not in hindsight. The convergence of AI electricity demand, government nuclear policy, and Big Tech balance sheet spending on 20-year power agreements is not a cyclical trade. This is a generational repositioning of the U.S. energy grid.

The U.S. generated roughly 100 gigawatts of nuclear power in 2024. The national goal is 400 gigawatts by 2050. Building 300 new gigawatts of nuclear capacity over the next 24 years means this is a multi-decade construction and fuel cycle — one that touches fleet operators, SMR developers, fuel producers, and grid infrastructure builders simultaneously.

Microsoft is restarting Three Mile Island. Meta is locking in 6.6 gigawatts of nuclear. Amazon is backing X-energy with $700 million. Google signed the first-ever corporate SMR fleet deal. These are not press release moves — these are 20-year balance sheet commitments from some of the most analytically rigorous capital allocators in the world. When Amazon, Microsoft, Google, and Meta all agree on the same energy strategy, it's worth paying attention.

The current may look calm on the surface. But underneath, there is a very large, very fast-moving nuclear trade forming. We'd rather be in the water early than watching from the shore.

Stay sharp. Stay liquid. Know your exit. And as always — happy hunting.

— The Sharkwater Trading Analysis Team


Disclaimer: This blog post is for informational and educational purposes only and should not be considered financial advice. The information presented reflects our research and analysis as of June 27, 2026, and may not remain accurate as market conditions, regulatory developments, and company circumstances change. Past performance of any stock or sector discussed is not indicative of future results. All investing involves risk, including the possible loss of principal. Nuclear energy stocks — particularly pre-revenue SMR developers — carry substantial speculative risk. Analyst price targets cited are third-party estimates and are not guarantees of future performance. Please consult with a qualified financial professional before making any investment decisions. Sharkwater Trading does not hold positions in any securities mentioned at the time of this writing, and this post does not constitute a solicitation to buy or sell any security.

🦈 What Makes mREITs a Unique Hunting Ground (ORC, MFA, AGNC, MFA)

By Sharkwater Trading Analysis Team  |  June 27, 2026

Calling all income-hunting Sharks! You've seen the headlines — yields of 13%, 15%, even 20% from mortgage REITs. Numbers like that make the average investor's jaw drop. But here at Sharkwater, we don't just chase the yield. We hunt the inefficiency hidden inside the yield.

Today we're diving deep on four of the most actively traded mREITs in the market: ORC (Orchid Island Capital), AGNC (AGNC Investment Corp), RITM (Rithm Capital), and MFA (MFA Financial). We're going to answer a question that most retail investors never even think to ask:

Is it more profitable to buy in before the ex-dividend date and ride the run-up — or to hold through and collect the payout?

Spoiler: the answer is different for every one of these four, and the reasons why will change the way you think about high-yield income investing forever. Let's get in the water.


🦈 What Makes mREITs a Unique Hunting Ground

Mortgage REITs are not your typical dividend stocks. They borrow money at short-term rates, invest it in mortgage-backed securities, and pay out the spread as dividends. When rates behave, the dividends are fat. When rates spike, book values erode and dividend cuts follow.

What makes them particularly interesting for traders is a structural quirk: every ex-dividend date is a mini-event. Short sellers — who are often heavily positioned in mREITs — must pay the dividend to their stock lenders every cycle. For monthly payers like ORC and AGNC, that's 12 times per year. That creates a rhythm of short-covering pressure in the days before each ex-date that savvy traders can exploit.

Add in the dividend capture community — buyers who scoop shares specifically to collect the dividend before selling — and you have a recurring, structural bid under these stocks in the 3–10 days before every ex-dividend date. Academic research (Lund University, ScienceDirect) confirms statistically significant pre-ex-date buying pressure (p = 0.008) across high-yield dividend stocks. These aren't random ripples. They're predictable tides.

Here's the snapshot on all four before we go deeper:

TickerPriceAnnual YieldDiv / EventFrequencyShort % FloatDiv Trend
ORC~$6.95~17–20%$0.10/moMonthly5.82%❌ Serial cuts
AGNC~$10.91~13–14%$0.12/moMonthly~8.0%✅ Stable since 2020
RITM~$9.28~10–11%$0.25/qtrQuarterly1.13%✅ Stable since 2021
MFA~$9.50~14–15%$0.36/qtrQuarterly~2–3%📈 Growing

🦈 ORC — Orchid Island Capital: The High-Yield Yield Trap

Let's start with the flashiest number in the group. ORC's 17–20% yield has been luring retail investors for years. And every year, a fresh batch of buyers learns the hard way that headline yield is not the same as total return.

ORC is an externally managed, pure-play agency mREIT — it buys nothing but agency residential mortgage-backed securities. That narrow mandate means it has almost no defense when the rate environment turns hostile. The proof is in the dividend history:

  • 2021: $0.065/month — stable, respectable
  • January 2022: Cut to $0.055 — Fed rate hike fears begin
  • March 2022: Cut again to $0.045 — rates keep climbing
  • Mid-2023: Brief spike to $0.16/month — elevated MBS spreads provided temporary relief
  • Early 2024: Cut back to $0.12
  • Late 2025/2026: Cut again to $0.10 — accompanied by a 7.8% same-day stock drop

That's at least four dividend cuts in five years, Sharks. The 20% yield advertised today was 13% six months ago. And it might be 10% by the time you read this. When you account for the consistent book value erosion and share price decay, the net total return for ORC holders over any meaningful multi-year period has been mediocre at best.

Short interest: ORC carries about 5.82% of float short (~10.66 million shares). Shorts pay $0.10/share to their lenders every month — roughly 17% of the stock's price per year in carry cost alone. That is an eye-watering cost to maintain a short position, which creates modest but recurring short-covering pressure before each monthly ex-date.

The pre-ex trade opportunity: The covering window is real but small. On a $6.95 stock, the $0.10 monthly dividend represents just 1.44% of the share price. That's within normal daily noise. Transaction costs can eat the entire edge if you're not careful.

The Trade (ORC)

  • Entry: D-5 to D-3 before ex-date (last business day of the month)
  • Exit: Day before ex-date — do NOT hold through the drop
  • Target gain: 0.3–0.8% per cycle
  • Verdict: Weakest capture candidate. Small absolute dividend makes the math tight. ORC is a trading vehicle only — not a long-term hold.

🦈 AGNC — AGNC Investment Corp: The King of the Capture Trade

If ORC is the flashy bait, AGNC is the patient apex predator. It's the largest agency mREIT by market cap, internally managed (a meaningful advantage over externally managed peers like ORC), and has maintained an unchanged $0.12/month dividend since early 2020 — over five years of consistency in a sector famous for cuts. That's remarkable.

Here's what makes AGNC the most compelling dividend capture candidate of the four:

The short interest math is staggering. AGNC carries approximately 90.76 million shares short — roughly 8% of its float. With a $0.12/month dividend, short sellers are collectively paying approximately $10.9 million per month in dividend payments to their stock lenders. Every. Single. Month. That is a structural, institutional-scale pressure to cover short positions before the end-of-month ex-date.

The timing is also uniquely predictable. AGNC consistently sets its ex-dividend date on the last business day of every month — no guessing, no surprises. Traders who want to front-run the short covering know exactly when to position. And with average daily volume exceeding 13 million shares, the stock is liquid enough to execute without moving the market against you.

The one caveat to keep in mind: AGNC currently trades at approximately 1.32× book value (stock ~$10.91 vs. book ~$8.25/share). That premium to book is a meaningful risk if the rate environment deteriorates. This is not a stock you want to fall asleep holding. The capture trade suits it perfectly precisely because you're not overstaying your welcome.

The Trade (AGNC)

  • Entry: D-7 to D-5 before ex-date (institutional covering typically begins building here)
  • Exit: Day before ex-date — collect the run-up, skip the drop
  • Target gain: 0.5–1.2% per cycle × 12 months = 6–14% annualized
  • Verdict: Best capture candidate in the group. High liquidity, predictable schedule, massive short covering pressure, tight bid-ask spreads. This is the trade you build the playbook around.

🦈 RITM — Rithm Capital: Don't Trade It. Own It.

Rithm Capital is the black sheep of this group — in the best possible way. When New Residential Investment Corp. rebranded as Rithm Capital in August 2022, it wasn't just a name change. It was a signal that this company was evolving beyond the pure-play mREIT model that makes stocks like ORC so vulnerable to rate cycles.

RITM has built meaningful businesses in mortgage servicing rights (MSRs) — which naturally appreciate in value when interest rates rise, providing a hedge against the MBS book value losses that hammer pure-play agency mREITs. It also owns Newrez LLC, one of the largest mortgage origination and servicing platforms in the country. This diversification fundamentally changes the risk profile.

The numbers tell the story:

  • Stock price: ~$9.28
  • Book value per share: ~$12.51 (Q1 2026)
  • Price-to-book: ~0.73× — trading at a 27% discount to book value
  • Analyst consensus: Strong Buy (11 analysts)
  • 12-month price target: $13.65 — implying nearly +49% upside from current levels
  • Quarterly dividend: $0.25/share — stable since 2021, $1.00 annualized
  • Short interest: A mere 1.13% of float

That last point matters for the capture strategy conversation. With barely any short sellers in the water, there's no significant short-covering tailwind before quarterly ex-dates. The pre-ex-date trade on RITM loses its most powerful engine.

But here's the thing, Sharks — when a stock trades at 73 cents on the dollar of book value, when 11 professional analysts say Strong Buy, when the 12-month target implies nearly 50% appreciation, you don't trade around the edges. You get a full position and let it work.

The Trade (RITM)

  • Strategy: Buy on weakness — particularly after any mREIT sector selloffs that drag all boats down regardless of fundamentals
  • Hold: Through multiple dividend cycles; this is a total-return play
  • Target: $13.65 analyst consensus (49% upside) + 10–11% yield while you wait
  • Verdict: The strongest risk-adjusted opportunity of the four. The capture trade is inferior here. Buy it, hold it, collect it.

🦈 MFA Financial: The Best Capture Math in the Pond

MFA Financial is the most interesting stock in this analysis for capture traders. Here's why: with a quarterly dividend of $0.36 per share on a ~$9.50 stock, every single ex-dividend date represents a 3.8% event. Compare that to AGNC's 1.1% or ORC's 1.44% — MFA's per-event dividend is more than double the monthly payers on a per-cycle basis.

A larger dividend means a larger gravitational pull of dividend capture buyers in the days before ex-date. It also means the dollar-magnitude run-up that pre-positions can exploit is proportionally larger. The math just works better.

MFA also stands out from a fundamental perspective. It's not a pure agency shop — MFA invests in non-QM loans, transitional loans, and residential whole loans, which gives it a different risk profile and better credit spread income. And uniquely among these four, MFA has been raising its dividend — from $0.35/quarter to $0.36/quarter most recently, signaling confidence in its earnings power.

One important housekeeping note: MFA executed a 1-for-4 reverse stock split in April 2022. Any pre-split dividend figures (which were around $0.10–$0.11/quarter) are not directly comparable to the current post-split $0.35–$0.36 range. Make sure you're looking at adjusted data if you're reviewing historical charts.

Short interest is moderate (~2–3% estimated), lower than ORC or AGNC, so the short-covering dynamic is present but not dominant. The primary driver of the pre-ex run-up here is pure dividend capture buyer demand attracted by the large per-event payout.

The Trade (MFA)

  • Entry: D-10 to D-7 before quarterly ex-date (end of March, June, September, December)
  • Exit: Day before ex-date — skip the opening drop
  • Target gain: 1.5–3.0% per cycle × 4 quarters = 6–12% annualized
  • Verdict: Best per-event capture math of the four. Larger dividend creates a more visible, more crowded run-up. Only 4 cycles per year keeps transaction costs manageable.

🦈 The Big Question Answered: Run-Up or Hold for the Dividend?

So what's the verdict? Here's the Sharkwater framework, broken down cleanly:

TickerBest StrategyKey ReasonAnnualized Target
AGNCCapture Trade ⚡$11M/month in short covering pressure; end-of-month timing is clockwork; best liquidity6–14%
MFACapture Trade ⚡Largest per-event dividend (3.8%); only 4 cycles/yr keeps costs low; growing dividend adds support6–12%
RITMHold + Collect 💰27% discount to book; 49% analyst upside; MSR hedge; Strong Buy consensus. Don't trade this one.10% yield + 20–49% appreciation potential
ORCTrade Only / Avoid Long ⚠️Serial dividend cutter; capital erosion consumes the yield; capture window exists but margin is thin3–6% (tight margin)

🦈 Short Interest: The Hidden Engine Behind the Run-Up

Let's spell out the mechanics so it's crystal clear. When you short a stock, you borrow shares from someone else's brokerage account. If that stock pays a dividend while you're short, you pay the dividend — not the lender. It comes out of your account and goes to the lender to compensate them for the income they missed.

For these four mREITs, that carry cost is brutal:

  • ORC: $1.20/share per year in dividend carry — approximately 17.3% of share price annually
  • AGNC: $1.44/share per year — approximately 13.2% of share price annually, paid to lenders by ~91 million short shares
  • MFA: $1.44/share per year — approximately 15.2% of share price annually
  • RITM: $1.00/share per year — approximately 10.8% of share price annually (but very few shorts to begin with)

No rational short seller carries this cost a single day longer than necessary. That's why you see a pattern of short covering building in the week before ex-date — particularly in AGNC and ORC where the monthly cadence makes this a recurring feature of the tape. It's not guaranteed to move the stock dramatically every single cycle, but it is a structural, repeating tailwind that adds to whatever organic buying demand is already in the market.


🦈 The Tax Angle You Can't Ignore

Here's the part most retail income investors skip entirely — and it changes the math significantly.

To qualify for the lower 15–20% long-term capital gains tax rate on dividends, you must hold the stock for at least 61 days around the ex-dividend date. If you're running a dividend capture strategy — buying 5–10 days before ex-date and selling the day before — your holding period is nowhere near 61 days.

That means dividends you collect during a capture strategy are taxed as ordinary income — potentially up to 37% depending on your bracket. Meanwhile, if you're trading the price run-up and selling before the ex-date, any gain is a short-term capital gain — also ordinary income rates, but you avoided the ex-date drop entirely and your gross return may be higher before tax.

The bottom line: for taxable accounts, capturing the price appreciation before ex-date is often more tax-efficient than holding through and collecting the dividend itself. Another point in favor of the capture trade over the hold strategy — especially for ORC and AGNC where no one should be holding long-term anyway.


🦈 Optimal Entry and Exit: Timing the Tide

Based on the structural dynamics above, here are the specific windows we watch for each ticker:

AGNC (Monthly — Last Business Day of Month)
Entry: D-7 to D-5 before ex-date  |  Exit: Day before ex-date
Why D-7? Institutional short-covering desks typically begin reducing exposure 5–7 business days before month-end to manage their carry cost exposure. Getting in before the bulk of that covering puts you on the right side of the flow.

MFA (Quarterly — End of March, June, September, December)
Entry: D-10 to D-7 before ex-date  |  Exit: Day before ex-date
Why earlier? The larger dividend ($0.36 = 3.8% of price) means more traders are trying to position in advance. The queue gets longer, so you want to be near the front. Enter early, let the crowd build behind you.

ORC (Monthly — Last Business Day of Month)
Entry: D-5 to D-3  |  Exit: Day before ex-date
Why shorter window? The $0.10 dividend is small enough that early entry risks whipsaw from unrelated market noise. Keep the hold period tight to minimize exposure to ORC's serial dividend cut risk.

RITM (Quarterly)
Don't time the ex-date. Just buy on weakness — ideally when the broader mREIT sector sells off — and hold for the total return story. The 49% analyst upside makes timing around a $0.25 quarterly dividend feel like rearranging deck chairs on a yacht.


🦈 Risks Every Shark Must Respect

We'd be doing you a disservice if we didn't lay out the risks clearly. This is a feeding ground, but these waters have teeth.

  • The run-up is structural, not guaranteed. If a major macro event hits — a surprise Fed announcement, a credit market shock, an earnings miss — it can override the pre-ex buying pressure entirely. You can enter a capture trade and have the stock go down in the days before ex-date.
  • Capital erosion is real. ORC and AGNC have both lost significant book value over the past five years. A 17% yield means very little if the stock price drops 12% per year. Track total return, not just yield.
  • AGNC's book value premium is a risk. Paying 1.32× book for an agency mREIT leaves you exposed if rates spike again and spreads widen. The capture trade keeps your holding period short specifically to manage this risk.
  • Transaction costs matter at scale. Running 12 capture trades per year on AGNC or ORC means 24 commissions (buy and sell). With a $0.12 dividend as the target, even small costs erode the edge. Size positions appropriately and use zero-commission platforms.
  • Tax drag in taxable accounts. As outlined above — all short-term gains and collected dividends in capture strategies are ordinary income. Model your after-tax return before committing to the strategy.

🦈 Final Verdict: The Sharkwater Call

After five years of data, structural analysis, and putting these four tickers through the grinder, here's where we stand:

RITM is the standout long-term opportunity. Trading at a 27% discount to book value with a 49% analyst price target and a diversified business model that includes natural rate hedges, this is the one you own, not trade. If you're an income investor and you only buy one of these four, make it RITM.

AGNC is the best capture trade machine. The combination of $10.9 million per month in short covering pressure, end-of-month predictability, and deep liquidity makes AGNC the most reliable pre-ex-date run-up candidate. Set your calendar, set your alerts, and execute the same playbook every month.

MFA is the best per-trade capture opportunity. Fewer cycles per year, but the $0.36 quarterly dividend creates the largest absolute run-up target. A growing dividend adds fundamental support. Good for traders who want quality over quantity.

ORC is a trading vehicle only. The headline yield is seductive. The reality — serial dividend cuts, chronic book value erosion, thin capture margins — makes it a poor fit for anything other than short-term tactical trades. Respect the tide, don't swim against it.

The water is warm out there, Sharks. Know which current you're swimming with — the income hold or the capture trade — and you'll navigate these mREITs better than 90% of the yield-chasing crowd.

Good luck out there. Stay sharp, stay liquid, and always know your exit before you enter.

— The Sharkwater Trading Analysis Team


Disclaimer: This blog post is for informational and educational purposes only and should not be considered financial advice. The information presented reflects our analysis as of the publication date and may not remain accurate as market conditions change. Past performance of any stock or strategy discussed is not indicative of future results. All investing involves risk, including the possible loss of principal. Dividend rates, book values, short interest data, and analyst targets cited are based on publicly available information and are subject to change. Please consult with a qualified financial professional before making any investment decisions. Sharkwater Trading does not guarantee the accuracy or completeness of any information contained in this post. 

Friday, May 29, 2026

War, Nukes, Rockets, REITS and Rates.

 SHARKWATERTRADING.COM

Macro Deep Dive • May 2026

WAR, NUKES,
ROCKETS & RATES

The full macro picture — Iran, nuclear energy, space stocks, REITs, and the tactical trades threading them all together.

May 20, 2026·SharkWater Trading·10 min read

This isn't a normal market. You have a Middle East war rattling global oil supply, a Federal Reserve without a permanent chair, nuclear energy being re-rated in real time, and the SpaceX IPO loading on the launchpad. Every one of these stories is moving markets independently — but they're also deeply connected underneath. Understanding the linkage is how you avoid getting jerked around by the headlines and start trading the map instead of the noise.

Let's go layer by layer.

01
THE IRAN WAR
The volatility engine driving everything else

Brent crude peak
~$120
From $72 pre-conflict
Brent now
~$94
Fragile ceasefire price
EU nat. gas spike
+38%
Single day, March 2026
Gold peak
$5,400
Haven demand surge
US CPI (March)
3.3%
Highest since May 2024

The U.S.-Israeli attack on Iran and the closure of the Strait of Hormuz created what the International Energy Agency called the "largest supply disruption in the history of the global oil market" — echoing the 1970s energy crisis. Oil swung from $72 to nearly $120 before settling around $94 as ceasefire talks began. Europe's natural gas posted its largest single-day gain since 2022. Gold briefly reclaimed $5,400. The volatility wasn't noise — it was the market genuinely repricing geopolitical risk.

Here's the key insight from Morgan Stanley: historically, the S&P 500 rises 8.4% on average in the 12 months following major external shocks — wars, pandemics, energy crises. That's reassuring long term. But the near-term risk is duration: if oil stays elevated, inflation stays hot, and the Fed stays frozen. The current ceasefire is fragile — a genuine breakthrough sends oil back to $80; a breakdown sends it above $110. You're trading a binary outcome structure, not a trend.

The second-order effects matter most for portfolio positioning. Energy sector outperformance, defense spending acceleration, food inflation risk, and — critically — pressure on the Fed not to cut even as the new chair wants to. All of those feed into the rest of this post.

"The market rallied on the ceasefire announcement — but Schwab's analysts noted it was driven by hedge unwinds, not fundamental resolution. The Strait isn't open. Infrastructure is damaged. Energy prices can stay elevated even after the guns go quiet."
02
NUCLEAR ENERGY
The Iran war just made the long-term case louder

Here's the paradox that should have your full attention: the same war that's spiking oil and gas prices is simultaneously making the case for nuclear energy stronger than ever. Energy security is no longer a theoretical argument — it's a daily front-page story. When a single strait closure can put Europe's heating costs up 38% in a day, governments and corporations are suddenly very motivated to find power sources that don't flow through chokepoints.

Layered on top of the geopolitical argument is the AI power demand story. Data centers are consuming electricity at an unprecedented rate. Every major hyperscaler — Microsoft, Google, Meta, Amazon — is signing nuclear power deals because it's the only carbon-free, always-on energy source that can deliver the load AI requires. Nuclear isn't just a hedge against war. It's the infrastructure backbone of the AI economy.

"Nuclear is no longer the 'alternative' energy play. It's the convergence of energy security, AI infrastructure, and geopolitical reality — all in one sector."
CEGPrice: $303
PT: $375
Constellation Energy
The blue chip. Largest nuclear operator in the U.S., pays a dividend, has existing long-term power agreements with Microsoft and others. The safest way into nuclear.
✓ Revenue now✓ DividendLow risk
GEVPrice: $1,040
PT: $1,240
GE Vernova
The picks-and-shovels nuclear play. Makes the turbines and grid infrastructure that every new nuclear plant needs — regardless of which reactor design wins.
✓ Infrastructure playLower volatility
OKLOPrice: $72
PT: $92
Oklo Inc.
Sam Altman-backed. Broke ground at Idaho National Lab. Partnered with Nvidia on AI-enabled reactor R&D. Acquiring Atomic Alchemy for medical isotopes — potential revenue before reactors go live. $1.6B cash runway. No commercial reactor yet.
✓ $1.6B cash✓ Nvidia partnershipPre-revenueHigh vol
SMRPrice: $12.55
PT: $16–19
NuScale Power
First NRC-approved SMR design in the U.S. 6 GW deal pipeline with TVA via ENTRA1. No commercial revenue yet — still in development. Cheapest entry into the SMR thesis. Paired bet with OKLO makes sense for speculative allocation.
✓ NRC approvedPre-revenueHigh vol
CCJPrice: $116
PT: $129
Cameco Corp
World's largest publicly traded uranium producer. The fuel-side play — as more reactors come online, uranium demand rises. More stable than SMR developers but moves with uranium spot prices.
✓ Revenue nowCommodity-linked
URAETF basket
Global X Uranium ETF
Holds Cameco, Oklo, Sprott Physical Uranium Trust, and international uranium exposure. The diversified basket approach for nuclear without picking individual winners.
✓ DiversifiedETF structure
03
SPACE STOCKS
The secular growth story hiding inside the geopolitical one

The Iran war has an underappreciated connection to space: the Golden Dome missile defense initiative is now a national security priority, not a budget line item. Defense spending is accelerating across satellite infrastructure, launch capacity, and space-based surveillance. That's a structural tailwind for the space sector that has nothing to do with the SpaceX IPO — and everything to do with it at the same time.

We've covered Rocket Lab's 20X run from $3–4 in 2024 and the full pre-IPO SpaceX playbook (XOVR, RONB, DXYZ, ARKVX, XOVL) in recent posts. The macro add here: if the Iran conflict extends, defense-adjacent space infrastructure spending accelerates. Space isn't just the next frontier — it's current operational theater. Companies providing launch, communications, and surveillance capabilities are defense contractors now.

Rocket Lab specifically is positioned at that intersection: smallsat launches for defense payloads, Neutron for larger missions, and a growing space systems business that hasn't been fully priced in yet. The SpaceX IPO, whenever it arrives, will re-rate the entire sector — not just the SpaceX proxy funds.

"Space isn't the next frontier anymore. It's current operational theater — and investors who treat it like a sci-fi bet are leaving defense-grade tailwinds on the table."
04
THE FED TRANSITION & REITs
New leadership, dovish tilt, and what it means for income

Current rate
3.5–3.75%
Held 3 meetings
New Fed chair
Warsh
Kevin Warsh nominated
Expected cuts
1–3
Post-chair, H2 2026
Target range
3–3.25%
iShares / ING forecast

Jerome Powell's term expired May 15. Kevin Warsh has been nominated as the next Fed chair — and while his confirmation has been delayed by Senate Republicans, the direction of travel is clear. Trump wants lower rates. His preferred candidates are dovish. Markets are pricing in 1–3 cuts in the back half of 2026, with the target rate moving toward 3%–3.25%.

Here's the complication: the Iran war has pushed CPI to 3.3% — the highest since May 2024 — and the Fed has held rates unchanged at three straight meetings precisely because cutting into an oil shock would be reckless. The new chair walks into a trap: political pressure to cut, inflation pressure not to. That tug-of-war creates uncertainty in the short term, but directional clarity over the medium term. Rates are going lower in 2026 — the question is when, not if.

For REIT investors, that setup is genuinely constructive. REITs are essentially rate-sensitive yield instruments — when the 10-year Treasury yield declines, REIT valuations improve and capital costs fall. The window between the first confirmed rate cut and full market repricing of REIT NAVs is typically where the best entry points live. That window may be opening right now.

"The new Fed chair inherits an inflation problem he didn't create and a president demanding cuts he may not be able to deliver immediately. But rates are going lower. Build your REIT position before the first cut headlines hit — not after."
EQIXData center REIT
Equinix
The AI-adjacent REIT play. Data center infrastructure for hyperscalers. Rate cuts improve development economics, and AI spending drives long-term occupancy. The best of both macro tailwinds in one name.
✓ AI infrastructure✓ Rate cut upside
DLRData center REIT
Digital Realty
EQIX's closest peer. Development yields improve meaningfully with a 25bp cut. Slightly more rate-sensitive than EQIX, making it a higher-beta bet on the rate cut thesis.
✓ Rate-cut leverageAI tenant base
AMTTower REIT
American Tower
Defensive REIT with contractual escalators — income doesn't depend on reletting risk. Cell tower leases are long-duration and inflation-linked. Holds up in volatility and benefits from rate cuts.
✓ Defensive✓ Contractual escalators
PSAStorage REIT
Public Storage
Self-storage is one of the most resilient REIT subsectors — people rent units in good times and bad. Low capex, strong free cash flow, and a haven-like quality during macro uncertainty.
✓ Recession resilientStable cash flow

One important flag: avoid office REITs and structurally challenged retail REITs regardless of rate cuts. Lower borrowing costs can't fix vacant floors or dying malls. Stick to data center, tower, and storage names where the underlying business fundamentals are intact.

05
TACTICAL PLAYBOOK
How to trade the volatility without abandoning the thesis

The mistake most retail investors make in a macro environment like this is binary thinking — either going full-risk or going to cash. The better approach is a tiered framework: core long-term positions that benefit from structural trends, tactical satellite positions that trade the volatility, and a hedge layer that protects the portfolio when the next headline hits.

CategoryTactical TradeRationaleTime Frame
EnergyLong XOM / CVX on ceasefire pullbacks in oilIntegrated majors with dividend coverage and downstream hedging. Outperform in elevated-price environments even if headline oil dips.Core position
EnergyTrade UCO (2X crude ETF) around Hormuz headlinesBinary event structure in Hormuz news makes leveraged crude a short-term momentum trade. Buy escalation, trim on ceasefire rally. Hard exits required.Short-term only
NuclearCore: CEG + GEV. Speculative: OKLO + SMR pairedLayer risk across the stack — established cash-flow names anchor, high-vol SMR developers for upside. URA ETF as diversified middle ground.Multi-year core
SpaceRKLB core hold; XOVR for SpaceX pre-IPORKLB still has Neutron optionality. XOVR for clean SpaceX ETF exposure. XOVL for IPO filing pop only — short-term leveraged play.Mixed — see post
REITsAccumulate EQIX, DLR, AMT ahead of first rate cutRate cut timing uncertain but directional. Entering before the confirmation headline means buying before the retail wave reprices the sector.Position now, hold 12–18mo
DefenseLMT, NOC, RTX on Golden Dome spendingIran war + Golden Dome = multi-year defense budget expansion. Missile defense, satellite comms, and launch infrastructure are the beneficiaries.Core position
HedgeGold position (GLD or physical) sized at 5–10%Gold at $5,400 still has room if Iran escalates or inflation re-accelerates. Pairs against the rate-cut thesis — if cuts are delayed, gold wins.Ongoing hedge
IncomeLadder short-duration bonds into the belly of the curveiShares notes opportunity in 2–5 year Treasuries as rate cuts approach. Capturing yield today while maintaining flexibility if cuts accelerate.6–18 month ladder
06
RISK MATRIX
Know which levers blow up which positions

⚠ HIGH RISK
Hormuz re-escalation. Oil back above $110 → inflation spikes → rate cuts pushed to 2027 → REITs and growth stocks re-rate lower. Gold wins, energy wins, everything else suffers.
⚠ HIGH RISK
New Fed chair surprises hawkish. If Warsh prioritizes inflation over Trump's rate-cut demands, the dovish playbook unwinds. REIT thesis delays, growth premium compresses.
⚡ MEDIUM RISK
SMR commercialization delays. OKLO and SMR are pre-revenue. Any setback in permitting, construction, or funding resets the story. Size accordingly — these are satellite positions, not anchors.
⚡ MEDIUM RISK
SpaceX IPO delays. Every SpaceX proxy (DXYZ, XOVR, RONB) gives back premium quickly if the IPO timeline slips. The thesis is intact long-term but the near-term catalyst evaporates.
✓ MANAGEABLE RISK
Ceasefire holds, oil dips to $80. Energy positions give back some gains. Rotate profits into REITs and nuclear on the dip. This is the ideal soft-landing scenario for the broader portfolio.
✓ MANAGEABLE RISK
Rate cuts come slower than expected. REITs tread water for another quarter. Add on weakness — the direction is confirmed, only the speed is uncertain. Patient money wins here.
🦈 The SharkWater Framework
The anchor:CEG, GEV, LMT, XOM — established cash-flow businesses that win across multiple macro scenarios. These don't need a catalyst. They need time.
The growth layer:OKLO + SMR paired bet, RKLB, XOVR for SpaceX — higher vol, longer horizon, sized appropriately. These are 3–5 year positions, not quarterly trades.
The income build:EQIX, DLR, AMT, PSA — accumulate ahead of rate cuts. The entry window before the first confirmed cut is typically the best one you'll get.
The tactical trades:UCO on Hormuz escalation, XOVL on SpaceX IPO filing, GLD as permanent hedge. Sized small, hard exits — these are trades, not investments.
The through-line:War, AI, energy security, and rate normalization are all pointing at the same sectors — nuclear, space, defense, and real assets. The macro is messy. The thesis isn't.
"The biggest macro mistake right now is treating each of these stories as isolated. The Iran war is an energy story. The energy story is a nuclear story. The nuclear story is an AI story. The AI story is a space and defense story. And the Fed story runs underneath all of it. Connect the threads — and trade the whole picture."
#MacroOutlook#Nuclear#Iran#SpaceStocks#REITs#OKLO#SMR#Fed#RateCuts#GoldenDome#Defense#RKLB
Not financial advice. All investment vehicles carry risk including total loss of capital. Geopolitical events, rate decisions, and regulatory changes can materially impact any of the sectors discussed. Leveraged ETFs like UCO and XOVL are short-term instruments subject to daily decay and are unsuitable for long-term holding. Always do your own due diligence. SharkWater Trading content is for educational and entertainment purposes only.